Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002581 stock hub

SHE/002581 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002581is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.9B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002581

In the news

Latest news · SHE/002581

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/En/a

P25 23.5P50 41.3P75 83.2

ROE-8.7

P25 -0.9P50 4.1P75 8.8

ROIC-8.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002581 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

CNY

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	476
Employees Change	-31%
Employees Change Percent	-6.11
Enterprise value	CNY 3.9B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000012Y5
Last refreshed	2026-05-10
Market cap	CNY 3.9B
Price	CNY 5.89
Price currency	CNY
Rev Per Employee	595,255.53x
Sector	Healthcare
Sic	2833
Symbol	she/002581
Website	https://www.sinobiowaymed.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.44%
EV Earnings	-29.1x
EV/FCF	-9.38x
EV/Sales	13.73x
FCF yield	-10.68%
P/B ratio	2.04x
P/S ratio	13.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-49.01%
EBITDA Margin	-36.06%
Gross margin	43.38%
Gross Profit	CNY 122.9M
Gross Profit Growth	-49.5%
Gross Profit Growth Q	88.81%
Gross Profit Growth3 Y	-19.7%
Gross Profit Growth5 Y	-8.14%
Net Income	CNY -133.7M
Net Income Growth Years	2%
Pretax Margin	-64.88%
Profit Margin	-47.17%
Profit Per Employee	CNY -280,796
ROA	-4.08
Roa5y	-3.82
ROCE	-7.17
ROE	-8.72
Roe5y	-3.37
ROIC	-8.07
Roic5y	-5.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-13.98%
Cagr1y	-20.53%
Cagr3y	-34.88%
Cagr5y	-20.89%
Div CAGR3	-53.58%
EPS Growth Years	2
Revenue Growth	-23.75x
Revenue Growth Q	37.35x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth3 Y	-8.36x
Revenue Growth5 Y	-0.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.13
Assets	CNY 2.1B
Cash	CNY 153.9M
Current Assets	CNY 629.3M
Current Liabilities	CNY 190.8M
Debt	CNY 57.6M
Debt Equity	CNY 0.03
Debt FCF	CNY -0.14
Equity	CNY 1.9B
Liabilities	CNY 185.8M
Long Term Assets	CNY 1.5B
Long Term Liabilities	CNY -5M
Net Cash	CNY 96.3M
Net Cash By Market Cap	CNY 2.48
Net Cash Growth	-68.45%
Net Debt Equity	CNY -0.05
Tangible Book Value	CNY 1.7B
Tangible Book Value Per Share	CNY 2.6
WACC	5.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.65
Inventory Turnover	1.57
Net Working Capital	CNY 294M
Quick ratio	2.74
Working Capital	CNY 403.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.19%
Dividend per share	CNY 0
Last Dividend	CNY 0.05

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-77.82%
1Y total return	-20.51%
200-day SMA	7.68
3Y total return	-72.4%
50-day SMA	7.56
50-day SMA vs 200-day SMA	50under200
5Y total return	-69%
All Time High	42.49
All Time High Change	-86.14%
All Time High Date	2015-12-01
All Time Low	5.5
All Time Low Change	7.09%
All Time Low Date	2019-08-15
ATR	0.27
Beta	0.23
Beta1y	0.01
Beta2y	0.26
Ch YTD	-21.47
High	6.15
High52	11.67
High52 Date	2025-07-04
High52ch	-49.53%
Low	5.8
Low52	5.8
Low52 Date	2026-05-08
Low52ch	0.34%
Ma50ch	-22.11%
Price vs 200-day SMA	-23.27%
RSI	24.78
RSI Monthly	35.76
RSI Weekly	32.77
Sharpe ratio	-0.62x
Sortino ratio	-0.78
Total Return	-0.19%
Tr YTD	-21.47
Tr1m	-17.97%
Tr1w	-8.11%
Tr3m	-19.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY -138.9M
Operating margin	-49.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	490,424,817%
Net Borrowing	-11,775,000
Shares Insiders	12.84%
Shares Institutions	8.26%
Shares Out	659,735,586
Shares Qo Q	-0.07%
Shares Yo Y	0.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -414.9M
Average Volume	5,576,897.55x
Bv Per Share	2.73
CAPEX	CNY -189.2M
Ch10y	-77.86
Ch1m	-17.97
Ch1w	-8.11
Ch1y	-20.51
Ch3m	-19.65
Ch3y	-72.4
Ch5y	-69
Ch6m	-28.52
Change	-3.28%
Change From Open	1.55
Close	6.09
Days Gap	-4.76
Depreciation Amortization	37,594,144
Dollar Volume	137,404,882.7
Earnings Date	2026-04-29
EBIT	CNY -138.9M
EBITDA	CNY -102.2M
EPS	CNY -0.2
F Score	0
FCF	CNY -414.9M
FCF EV Yield	-10.67x
FCF Per Share	CNY -0.63
Financing CF	-28,194,969
Fiscal Year End	December
Founded	2,000
Income Tax	CNY -14.6M
Investing CF	-44,581,355
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2025-12-31
Ma150	7.67
Ma150ch	-23.19%
Ma20	7.1
Ma20ch	-16.98%
Net CF	-298,436,648
Next Earnings Date	2026-08-24
Open	5.8
Position In Range	25.71
Ppne	350,087,646
Price Date	2026-05-08
Ptbv Ratio	2.27
Relative Volume	5.15x
Revenue	283,341,632x
Tax By Revenue	-5.16x
Tr6m	-28.52%
Volume	23,328,503

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SHE/002581 pay a dividend?

Capital-return profile for this ticker.

Performance

SHE/002581 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002581?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.3%

Share of float held by funds and institutions

Insider ownership

+12.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

SHE/002581 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

24.8

Below 30: short-term oversold

Price vs 200-day MA

-23.3%

50/200-day relationship not available

Beta (5Y)

0.23

Less volatile than the market

Sharpe ratio

-0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002581

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002581 stock rating?

she/002581 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002581 analysis?

The full report lives at /stocks/she/002581/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002581?

The latest report frames she/002581 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002581 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.